Cytori Cell Research Institute, Inc. Price (3750.T)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

8,958,859

(0.3395)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Cytori Cell Research Institute, Inc.
news-img

Income Statement

Cytori Cell Research Institute, Inc.

Currency: JPY

YEAR 2019 2020 2021 2022 2023
Revenue
Revenue 1,180,000,000.00

+0%

1,388,292,000.00

+18%

1,335,578,000.00

-4%

2,144,712,000.00

+61%

1,560,388,000.00

-27%

Cost of Revenue
Cost of Revenue 424,000,000.00 627,969,000.00 476,345,000.00 875,724,000.00 268,000,000.00
Gross Profit
Gross Profit 756,000,000.00

+0%

760,323,000.00

+1%

859,233,000.00

+13%

1,268,988,000.00

+48%

1,292,388,000.00

+2%

Gross Profit Ratio (0.64%) (0.55%) (0.64%) (0.59%) (0.83%)
Operating Expenses
Research and Development 0.00 0.00 32,000,000.00 145,235,000.00 351,353,000.00
General and Administrative 155,240,000.00 0.00 134,000,000.00 152,000,000.00 0.00
Selling, General & Admin... 155,240,000.00 1,268,000,000.00 1,085,000,000.00 1,783,000,000.00 1,506,000,000.00
Selling & Marketing Exp... 0.00 0.00 951,000,000.00 1,631,000,000.00 0.00
Depreciation and Amortiz... 172,000,000.00 307,851,000.00 321,045,000.00 331,491,000.00 254,310,000.00
Other Expenses 0.00 84,597,000.00 156,689,000.00 73,005,000.00 207,000,000.00
Total Operating Expenses 393,000,000.00 1,491,992,000.00 1,321,556,000.00 2,063,346,000.00 2,065,353,000.00
Cost and Exponses 817,000,000.00 2,119,961,000.00 1,797,901,000.00 2,939,070,000.00 2,333,130,000.00
Operating Income
Operating Income -129,000,000.00

+0%

-731,671,000.00

+467%

-462,323,000.00

-37%

-794,359,000.00

+72%

-772,742,000.00

-3%

Operating Income Ratio (-0.11%) (-0.53%) (-0.35%) (-0.37%) (-0.50%)
Other Income and Exp...
Interest Income 0.00 0.00 0.00 0.00 0.00
Interest Expenses 57,470,000.00 84,537,000.00 93,194,000.00 129,241,000.00 153,811,000.00
Total Other Income/Exp... 448,000,000.00 77,428,000.00 396,987,000.00 -371,717,000.00 -238,471,000.00
EBITDA
EBITDA 43,000,000.00 -261,855,000.00 348,901,999.00 -705,344,000.00 -603,091,000.00
EBITDA ratio (0.04%) (-0.24%) (0.01%) (-0.18%) (-0.39%)
Income Before Tax
Income Before Tax 319,000,000.00 -654,243,000.00 -65,336,000.00 -1,166,076,000.00 -1,011,213,000.00
Income Before Tax Ratio (0.27%) (-0.47%) (-0.05%) (-0.54%) (-0.65%)
Income Tax Expense
Income Tax Expense 1,000,000.00 121,202,000.00 11,757,000.00 -106,345,000.00 -1,150,152,000.00
Net Income
Net Income 319,000,000.00

+0%

-831,863,000.00

-361%

-77,633,000.00

-91%

-1,059,941,000.00

+1,265%

138,155,000.00

-113%

Net Income Ratio (0.27%) (-0.60%) (-0.06%) (-0.49%) (0.09%)
Earning Per Share
Basic EPS 47.52 -101.64 -8.79 -118.71 15.47
Diluted EPS 47.52 -101.64 -8.79 -118.71 15.42
Share Outstanding
Basic Share Outstanding 6,712,293.00 8,184,400.00 8,829,847.00 8,928,548.00 8,928,377.00
Diluted Share Outstanding 6,712,293.00 8,184,400.00 8,829,847.00 8,928,548.00 8,958,859.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation